Ledger.Open graph →
SEC Form D · filed March 15, 2023

Virax Biolabs Group Ltd

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
London, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Mark A. Ternouth · London, United KingdomExecYair A. Erez · London, United KingdomDirectorJames A. Foster · London, United KingdomExec · DirectorEvan A. Norton · London, United KingdomDirectorLarry Marsh · NEW YORK, NYExec · DirectorBryan Sekino · NEW YORK, NYExecDan Sollof · NEW YORK, NYDirectorMichael Doyle · NEW YORK, NYDirectorJason M. Davis · London, United KingdomExecNelson M. Haight · London, United KingdomDirectorCameron A. Shaw · London, United KingdomExec · DirectorTomasz M. George · London, United KingdomExecKristen Yarbou · Dallas, TXDirectorMatthew Brennan · Dallas, TXExec · DirectorJake Bender · Dallas, TXDirectorCraig Mcneil · Dallas, TXExecJason M. Davis · London, United KingdomExecNelson M. Haight · London, United KingdomDirectorCameron A. Shaw · London, United KingdomExec · DirectorTomasz M. George · London, United KingdomExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗